This course, offered by Mayo Clinic in cooperation with TGen, Honor Health, and the Pancreatic Cancer Action Network, welcomes expert faculty from across the country and throughout Mayo Clinic to bring you a state-of-the-art conference with the latest treatment options in Hepato-Biliary and Pancreatic cancer. The program is designed to provide a multi-disciplinary overview regarding molecular characteristics, the importance of early diagnosis, treatment considerations, which includes surgery and new pharmacological agents, and how to incorporate these into clinical practice.
Topics include: Oncologic imaging and staging for the non-radiologist; molecular biology and translational research advances of pancreatic and hepato-biliary cancers, local therapy, surgery and liver transplantation for hepato-biliary cancers; adjuvant therapy and preoperative therapy of pancreatic and hepato-biliary cancers; targeted agents and treatment of molecular subsets for pancreatic and hepatobiliary cancers; first and second line therapy for advanced pancreatic and hepatobiliary cancers. Course format will include didactic lectures, panel discussions and use of interactive keypads.